Our previous studies have confirmed that MSC-sEV can significantly reduce blood glucose levels in type 2 diabetic rats, promote insulin secretion, accelerate liver glycogen synthesis [30], and inhibit renal interstitial fibrosis in a unilateral ureteral obstruction rat model [11]. This evidence concerns the gene INS and type 2 diabetes mellitus.